Optimizing thymic recovery in HIV patients through multidrug therapies
- Autores
- Costanza, Vicente; Rivadeneira Paz, Pablo Santiago; Biafore, Federico Leonardo; D'attellis, Carlos Enrique
- Año de publicación
- 2012
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- A control-theoretic approach to the problem of designing `low-side-effects´ therapies for HIV patients based on highly active drugs is substantiated here. The evolution of side-effects during treatment is modelled by an extra differential equation coupled to the dynamics of virions, healthy T-cells, and infected ones. The new equation reflects the dependence of collateral damages on the amount of each dose administered to the patient, and on the evolution of the viral load detected by periodical blood analyses. The cost objective accounts for recommended bounds on healthy cells and virions, and also penalizes the appearance of collateral malignancies caused by the medication. The problem is solved by a hybrid Dynamic Programming scheme that adhere to discrete-time observation and control actions, but maintaining the continuous-time setup for predicting states and side-effects. The resulting optimal strategies employ less drugs than those prescribed by previous optimization studies, but maintaining high doses at the beginning and the end of each period of six months. If an inverse discount rate is applied to favor early actions, and under a mild penalization of the final viral load, then the optimal doses are found to be high at the beginning and decrease afterwards, causing a desirable stabilization of the main variables.
Fil: Costanza, Vicente. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Santa Fe. Instituto de Desarrollo Tecnológico Para la Industria Química (i); Argentina
Fil: Rivadeneira Paz, Pablo Santiago. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Santa Fe. Instituto de Desarrollo Tecnológico Para la Industria Química (i); Argentina
Fil: Biafore, Federico Leonardo. Universidad Favaloro; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: D'attellis, Carlos Enrique. Universidad Nacional de San Martín. Escuela de Ciencia y Tecnología; Argentina. Universidad Favaloro; Argentina - Materia
-
Antiretroviral Drugs
Optimal Control
Nonlinear Dynamics
Dynamic Programming - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/10903
Ver los metadatos del registro completo
id |
CONICETDig_d72a01e375149e8b8d0e4abe81b426e1 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/10903 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Optimizing thymic recovery in HIV patients through multidrug therapiesCostanza, VicenteRivadeneira Paz, Pablo SantiagoBiafore, Federico LeonardoD'attellis, Carlos EnriqueAntiretroviral DrugsOptimal ControlNonlinear DynamicsDynamic Programminghttps://purl.org/becyt/ford/2.6https://purl.org/becyt/ford/2A control-theoretic approach to the problem of designing `low-side-effects´ therapies for HIV patients based on highly active drugs is substantiated here. The evolution of side-effects during treatment is modelled by an extra differential equation coupled to the dynamics of virions, healthy T-cells, and infected ones. The new equation reflects the dependence of collateral damages on the amount of each dose administered to the patient, and on the evolution of the viral load detected by periodical blood analyses. The cost objective accounts for recommended bounds on healthy cells and virions, and also penalizes the appearance of collateral malignancies caused by the medication. The problem is solved by a hybrid Dynamic Programming scheme that adhere to discrete-time observation and control actions, but maintaining the continuous-time setup for predicting states and side-effects. The resulting optimal strategies employ less drugs than those prescribed by previous optimization studies, but maintaining high doses at the beginning and the end of each period of six months. If an inverse discount rate is applied to favor early actions, and under a mild penalization of the final viral load, then the optimal doses are found to be high at the beginning and decrease afterwards, causing a desirable stabilization of the main variables.Fil: Costanza, Vicente. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Santa Fe. Instituto de Desarrollo Tecnológico Para la Industria Química (i); ArgentinaFil: Rivadeneira Paz, Pablo Santiago. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Santa Fe. Instituto de Desarrollo Tecnológico Para la Industria Química (i); ArgentinaFil: Biafore, Federico Leonardo. Universidad Favaloro; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: D'attellis, Carlos Enrique. Universidad Nacional de San Martín. Escuela de Ciencia y Tecnología; Argentina. Universidad Favaloro; ArgentinaElsevier2012-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/10903Costanza, Vicente; Rivadeneira Paz, Pablo Santiago; Biafore, Federico Leonardo; D'attellis, Carlos Enrique; Optimizing thymic recovery in HIV patients through multidrug therapies; Elsevier; Biomedical Signal Processing And Control; 8; 1; 5-2012; 90-971746-8094enginfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.bspc.2012.06.002info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S1746809412000705info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:45:01Zoai:ri.conicet.gov.ar:11336/10903instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:45:01.951CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Optimizing thymic recovery in HIV patients through multidrug therapies |
title |
Optimizing thymic recovery in HIV patients through multidrug therapies |
spellingShingle |
Optimizing thymic recovery in HIV patients through multidrug therapies Costanza, Vicente Antiretroviral Drugs Optimal Control Nonlinear Dynamics Dynamic Programming |
title_short |
Optimizing thymic recovery in HIV patients through multidrug therapies |
title_full |
Optimizing thymic recovery in HIV patients through multidrug therapies |
title_fullStr |
Optimizing thymic recovery in HIV patients through multidrug therapies |
title_full_unstemmed |
Optimizing thymic recovery in HIV patients through multidrug therapies |
title_sort |
Optimizing thymic recovery in HIV patients through multidrug therapies |
dc.creator.none.fl_str_mv |
Costanza, Vicente Rivadeneira Paz, Pablo Santiago Biafore, Federico Leonardo D'attellis, Carlos Enrique |
author |
Costanza, Vicente |
author_facet |
Costanza, Vicente Rivadeneira Paz, Pablo Santiago Biafore, Federico Leonardo D'attellis, Carlos Enrique |
author_role |
author |
author2 |
Rivadeneira Paz, Pablo Santiago Biafore, Federico Leonardo D'attellis, Carlos Enrique |
author2_role |
author author author |
dc.subject.none.fl_str_mv |
Antiretroviral Drugs Optimal Control Nonlinear Dynamics Dynamic Programming |
topic |
Antiretroviral Drugs Optimal Control Nonlinear Dynamics Dynamic Programming |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/2.6 https://purl.org/becyt/ford/2 |
dc.description.none.fl_txt_mv |
A control-theoretic approach to the problem of designing `low-side-effects´ therapies for HIV patients based on highly active drugs is substantiated here. The evolution of side-effects during treatment is modelled by an extra differential equation coupled to the dynamics of virions, healthy T-cells, and infected ones. The new equation reflects the dependence of collateral damages on the amount of each dose administered to the patient, and on the evolution of the viral load detected by periodical blood analyses. The cost objective accounts for recommended bounds on healthy cells and virions, and also penalizes the appearance of collateral malignancies caused by the medication. The problem is solved by a hybrid Dynamic Programming scheme that adhere to discrete-time observation and control actions, but maintaining the continuous-time setup for predicting states and side-effects. The resulting optimal strategies employ less drugs than those prescribed by previous optimization studies, but maintaining high doses at the beginning and the end of each period of six months. If an inverse discount rate is applied to favor early actions, and under a mild penalization of the final viral load, then the optimal doses are found to be high at the beginning and decrease afterwards, causing a desirable stabilization of the main variables. Fil: Costanza, Vicente. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Santa Fe. Instituto de Desarrollo Tecnológico Para la Industria Química (i); Argentina Fil: Rivadeneira Paz, Pablo Santiago. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Santa Fe. Instituto de Desarrollo Tecnológico Para la Industria Química (i); Argentina Fil: Biafore, Federico Leonardo. Universidad Favaloro; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: D'attellis, Carlos Enrique. Universidad Nacional de San Martín. Escuela de Ciencia y Tecnología; Argentina. Universidad Favaloro; Argentina |
description |
A control-theoretic approach to the problem of designing `low-side-effects´ therapies for HIV patients based on highly active drugs is substantiated here. The evolution of side-effects during treatment is modelled by an extra differential equation coupled to the dynamics of virions, healthy T-cells, and infected ones. The new equation reflects the dependence of collateral damages on the amount of each dose administered to the patient, and on the evolution of the viral load detected by periodical blood analyses. The cost objective accounts for recommended bounds on healthy cells and virions, and also penalizes the appearance of collateral malignancies caused by the medication. The problem is solved by a hybrid Dynamic Programming scheme that adhere to discrete-time observation and control actions, but maintaining the continuous-time setup for predicting states and side-effects. The resulting optimal strategies employ less drugs than those prescribed by previous optimization studies, but maintaining high doses at the beginning and the end of each period of six months. If an inverse discount rate is applied to favor early actions, and under a mild penalization of the final viral load, then the optimal doses are found to be high at the beginning and decrease afterwards, causing a desirable stabilization of the main variables. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-05 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/10903 Costanza, Vicente; Rivadeneira Paz, Pablo Santiago; Biafore, Federico Leonardo; D'attellis, Carlos Enrique; Optimizing thymic recovery in HIV patients through multidrug therapies; Elsevier; Biomedical Signal Processing And Control; 8; 1; 5-2012; 90-97 1746-8094 |
url |
http://hdl.handle.net/11336/10903 |
identifier_str_mv |
Costanza, Vicente; Rivadeneira Paz, Pablo Santiago; Biafore, Federico Leonardo; D'attellis, Carlos Enrique; Optimizing thymic recovery in HIV patients through multidrug therapies; Elsevier; Biomedical Signal Processing And Control; 8; 1; 5-2012; 90-97 1746-8094 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.bspc.2012.06.002 info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S1746809412000705 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613416033976320 |
score |
13.070432 |